MX360389B - Formulacion farmaceutica o nutraceutica resistente a fluidos gastricos que comprende una o mas sales de acido alginico. - Google Patents
Formulacion farmaceutica o nutraceutica resistente a fluidos gastricos que comprende una o mas sales de acido alginico.Info
- Publication number
- MX360389B MX360389B MX2013001824A MX2013001824A MX360389B MX 360389 B MX360389 B MX 360389B MX 2013001824 A MX2013001824 A MX 2013001824A MX 2013001824 A MX2013001824 A MX 2013001824A MX 360389 B MX360389 B MX 360389B
- Authority
- MX
- Mexico
- Prior art keywords
- gastric resistant
- salts
- alginic acid
- pharmaceutical
- resistant pharmaceutical
- Prior art date
Links
- 230000002496 gastric effect Effects 0.000 title abstract 4
- 239000002417 nutraceutical Substances 0.000 title abstract 4
- 235000021436 nutraceutical agent Nutrition 0.000 title abstract 4
- 229960001126 alginic acid Drugs 0.000 title abstract 2
- 235000010443 alginic acid Nutrition 0.000 title abstract 2
- 229920000615 alginic acid Polymers 0.000 title abstract 2
- 239000000783 alginic acid Substances 0.000 title abstract 2
- 150000004781 alginic acids Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000011247 coating layer Substances 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se relaciona con una composición farmacéutica o nutracéutica resistente a fluidos gástricos que comprende un núcleo, que comprende un ingrediente farmacéutico o nutracéutico activo y una capa de recubrimiento resistente a fluidos gástricos sobre el núcleo, en donde la liberación del ingrediente farmacéutico o nutracéutico activo es no mayor de 15% bajo condiciones in vitro a pH 1.2 durante 2 horas en un medio de acuerdo con USP y con y sin la adición de etanol 40 (v/v), en donde la capa de recubrimiento resistente a fluidos gástricos comprende 10 a 100 en peso de una o más sales de ácido algínico con una viscosidad de 30 a 720 cP de una solución acuosa 1%.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2378CH2010 | 2010-08-18 | ||
| PCT/EP2011/055809 WO2012022498A1 (en) | 2010-08-18 | 2011-04-13 | Gastric resistant pharmaceutical or nutraceutical formulation comprising one or more salts of alginic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013001824A MX2013001824A (es) | 2013-03-08 |
| MX360389B true MX360389B (es) | 2018-10-31 |
Family
ID=44168760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013001824A MX360389B (es) | 2010-08-18 | 2011-04-13 | Formulacion farmaceutica o nutraceutica resistente a fluidos gastricos que comprende una o mas sales de acido alginico. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9492394B2 (es) |
| EP (1) | EP2605759B1 (es) |
| JP (1) | JP5705319B2 (es) |
| KR (1) | KR101873075B1 (es) |
| CN (1) | CN103068376B (es) |
| AU (1) | AU2011290958B2 (es) |
| BR (1) | BR112013003581B8 (es) |
| CA (1) | CA2808546C (es) |
| ES (1) | ES2716550T3 (es) |
| MX (1) | MX360389B (es) |
| RU (1) | RU2013111605A (es) |
| WO (1) | WO2012022498A1 (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101973235B1 (ko) * | 2012-08-27 | 2019-08-16 | 에보니크 룀 게엠베하 | 에탄올의 영향에 대해 지속 방출 특성 및 내성을 갖는 제약 또는 기능식품 조성물 |
| EP2887925B1 (en) * | 2012-08-27 | 2017-02-22 | Evonik Röhm GmbH | Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol |
| EP2906202A4 (en) * | 2012-10-15 | 2016-04-27 | Isa Odidi | ORAL DRUG RELIEF FORMULATIONS |
| CN104688775A (zh) * | 2013-12-04 | 2015-06-10 | 博晖(大连)实业有限公司 | 一种含海星成份的组合胃药 |
| US9895318B2 (en) * | 2014-02-17 | 2018-02-20 | Evonik Roehm Gmbh | Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol |
| CA2910865C (en) | 2014-07-15 | 2016-11-29 | Isa Odidi | Compositions and methods for reducing overdose |
| CA2936746C (en) * | 2014-10-31 | 2017-06-27 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
| US20170367985A1 (en) * | 2014-12-23 | 2017-12-28 | Fmc Corporation | Enteric Film Coating Compositions, Method of Coating, and Coated Forms |
| EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
| ES2838816T3 (es) | 2015-06-05 | 2021-07-02 | Evonik Operations Gmbh | Composición farmacéutica o nutracéutica con resistencia contra la influencia de etanol |
| EP3167879A1 (en) * | 2015-11-10 | 2017-05-17 | Evonik Technochemie GmbH | Gastric retention active delivery systems |
| JP6801203B2 (ja) * | 2016-03-18 | 2020-12-16 | 日油株式会社 | ｐＨ応答溶出性被覆造粒物および食品 |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| JP7111104B2 (ja) * | 2017-08-09 | 2022-08-02 | ライオン株式会社 | コーティング組成物、コーティング膜、コーティング製剤及びその製造方法 |
| WO2019072877A1 (en) * | 2017-10-10 | 2019-04-18 | Capsugel Belgium Nv | GETTING MULTIPARTICULAR COMPOSITIONS |
| KR20220035156A (ko) * | 2019-07-16 | 2022-03-21 | 아스트라제네카 아베 | 베리누라드를 포함하는 과량 방출 저항성 약제학적 조성물 |
| CN117794518A (zh) | 2021-07-29 | 2024-03-29 | 营养与生物科学美国1有限责任公司 | 控释包衣剂 |
| EP4176874A1 (en) | 2021-11-09 | 2023-05-10 | Evonik Operations GmbH | Pharmaceutical or nutraceutical composition with an alcohol resistant single layer coating system |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0725663B2 (ja) | 1985-03-11 | 1995-03-22 | 大正製薬株式会社 | 腸溶性軟カプセルの製造方法 |
| US5882715A (en) | 1995-06-20 | 1999-03-16 | Pharma-Vinci A/S | Method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method |
| US5811126A (en) * | 1995-10-02 | 1998-09-22 | Euro-Celtique, S.A. | Controlled release matrix for pharmaceuticals |
| DE10011447A1 (de) | 2000-03-10 | 2001-09-20 | Roehm Gmbh | Dispersion mit nichtionischem Emulgator |
| US6544556B1 (en) * | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
| US6620426B2 (en) | 2001-06-05 | 2003-09-16 | Isp Investments Inc. | Tablet coating composition |
| US20040253309A1 (en) * | 2003-01-27 | 2004-12-16 | Yamanouchi Pharmaceutical Co., Ltd. | Enteric sustained-release fine particles of tamsulosin and its salt and manufacturing method thereof |
| JP2004249231A (ja) | 2003-02-21 | 2004-09-09 | Takeda Chem Ind Ltd | 粒状物の製造方法とその装置 |
| GB0320020D0 (en) * | 2003-08-27 | 2003-10-01 | Mw Encap Ltd | Improved formulation for providing an enteric coating material |
| DE102004011349A1 (de) | 2004-03-05 | 2005-09-22 | Basf Ag | Wässrige Polymerdispersion auf Basis von Alkyl(meth)-acrylaten |
| TW200533391A (en) | 2004-03-25 | 2005-10-16 | Sun Pharmaceutical Ind Ltd | Gastric retention drug delivery system |
| KR20070007868A (ko) * | 2004-03-31 | 2007-01-16 | 비피에스아이 홀딩스, 인코포레이션. | 경구 섭취 가능한 기질용 장용성 피복 |
| AU2005249367A1 (en) * | 2004-04-16 | 2005-12-15 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and prokinetic agent |
| KR100676075B1 (ko) * | 2005-02-17 | 2007-02-01 | 한국유나이티드제약 주식회사 | 경구투여용 클래리스로마이신 함유 펠렛 제제 |
| CN101111230B (zh) * | 2005-03-29 | 2010-05-19 | 赢创罗姆有限责任公司 | 包含对活性成分具有调节释放作用的小丸的多颗粒药用形式 |
| US7645802B2 (en) * | 2005-06-27 | 2010-01-12 | Biovail Laboratories International Srl. | Bupropion hydrobromide and therapeutic applications |
| US9048951B2 (en) | 2005-09-02 | 2015-06-02 | Georgios Margaritis | Free space optics photodetector and transceiver |
| US20070104789A1 (en) | 2005-11-04 | 2007-05-10 | Donald Spector | Gastro-resistant and ethanol-resistant controlled-release formulations comprising hydromorphone |
| US8123849B2 (en) * | 2005-11-29 | 2012-02-28 | Ideal Cures Pvt. Ltd. | Aqueous film coating composition containing sodium alginate and preparation thereof |
| BRPI0809563A2 (pt) | 2007-03-29 | 2014-09-16 | Panacea Biotec Ltd | Formas de dosagem modificadas de tacrolimus |
| WO2009017716A2 (en) | 2007-07-27 | 2009-02-05 | Depomed, Inc. | Pulsatile gastric retentive dosage forms |
| MX2010003032A (es) | 2007-09-21 | 2010-04-09 | Evonik R Hm Gmbh | Composicion farmaceutica opioide de liberacion controlada ph dependiente con resistencia contra la influencia del etanol. |
-
2011
- 2011-04-13 BR BR112013003581A patent/BR112013003581B8/pt not_active IP Right Cessation
- 2011-04-13 MX MX2013001824A patent/MX360389B/es active IP Right Grant
- 2011-04-13 CA CA2808546A patent/CA2808546C/en active Active
- 2011-04-13 WO PCT/EP2011/055809 patent/WO2012022498A1/en not_active Ceased
- 2011-04-13 CN CN201180040052.6A patent/CN103068376B/zh not_active Expired - Fee Related
- 2011-04-13 KR KR1020137006647A patent/KR101873075B1/ko not_active Expired - Fee Related
- 2011-04-13 ES ES11714754T patent/ES2716550T3/es active Active
- 2011-04-13 AU AU2011290958A patent/AU2011290958B2/en not_active Ceased
- 2011-04-13 JP JP2013524383A patent/JP5705319B2/ja not_active Expired - Fee Related
- 2011-04-13 RU RU2013111605/15A patent/RU2013111605A/ru not_active Application Discontinuation
- 2011-04-13 US US13/086,079 patent/US9492394B2/en not_active Expired - Fee Related
- 2011-04-13 EP EP11714754.6A patent/EP2605759B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| EP2605759A1 (en) | 2013-06-26 |
| RU2013111605A (ru) | 2014-09-27 |
| AU2011290958A1 (en) | 2013-04-04 |
| US9492394B2 (en) | 2016-11-15 |
| WO2012022498A1 (en) | 2012-02-23 |
| BR112013003581A2 (pt) | 2016-06-07 |
| AU2011290958B2 (en) | 2014-06-19 |
| HK1182003A1 (zh) | 2013-11-22 |
| BR112013003581B8 (pt) | 2022-07-05 |
| US20120093926A1 (en) | 2012-04-19 |
| CA2808546C (en) | 2018-02-20 |
| CA2808546A1 (en) | 2012-02-23 |
| ES2716550T3 (es) | 2019-06-13 |
| KR20130099944A (ko) | 2013-09-06 |
| BR112013003581B1 (pt) | 2021-07-13 |
| EP2605759B1 (en) | 2018-11-21 |
| KR101873075B1 (ko) | 2018-06-29 |
| CN103068376A (zh) | 2013-04-24 |
| CN103068376B (zh) | 2016-04-20 |
| MX2013001824A (es) | 2013-03-08 |
| JP2013535509A (ja) | 2013-09-12 |
| JP5705319B2 (ja) | 2015-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX360389B (es) | Formulacion farmaceutica o nutraceutica resistente a fluidos gastricos que comprende una o mas sales de acido alginico. | |
| AU2016219654A1 (en) | Crystallization method and bioavailability | |
| BR112012026596A2 (pt) | método para preparar composições farmacêuticas pretendidas para administração oral compreendendo um ou mais ingredientes ativos e as composições que compreendem as mesmas | |
| AU2016219653A1 (en) | Crystallization Method and Bioavailability | |
| MX2010010647A (es) | Proceso para preparar formulaciones de dabigatran para administracion oral. | |
| TN2014000442A1 (en) | A delayed release drug formulation | |
| WO2010081824A3 (en) | Active coating of pharmaceutical dosage forms | |
| CO6771409A2 (es) | Acidos 1-bencilcicloalquilcarboxilicos sustituidos y su uso | |
| GEP20135919B (en) | Benzoic acid (1-phenyl-2-pyridin-4-yl) ethyl esters as phosphodiesterase inhibitors | |
| UA105229C2 (uk) | Фармацевтичний склад | |
| NZ610701A (en) | Once daily formulation of lacosamide | |
| WO2011086531A3 (en) | New anti-malarial agents | |
| MX2011012122A (es) | Derivados de tiofeno. | |
| PH12013500923A1 (en) | Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative | |
| WO2012006474A3 (en) | Compounds and methods for inhibiting phosphate transport | |
| WO2012064126A3 (ko) | 의료용 접착제 조성물 | |
| MX2013014142A (es) | Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol. | |
| MX2011011829A (es) | Composicion para suministro sostenido de farmaco que comprende un aglutinante geopolimerico. | |
| UA102254C2 (ru) | Жидкий состав для деферипрона с приятным вкусом | |
| WO2010090494A3 (ko) | 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도 | |
| WO2012074830A3 (en) | Modified release tranexamic acid formulation | |
| UA122762C2 (uk) | Пероральна композиція 9-[(2,2-диметилпропіламіно)-метил]-міноцикліну або його солі, тверда пресована дозована форма, композиція для ін'єкцій, застосування та спосіб приготування фармацевтичної композиції | |
| BR112014009242A2 (pt) | nanossuspensão farmacêutica | |
| BR112012021445B8 (pt) | formulação farmacêutica ou neutracêutica, e uso de um agente promotor de biodisponibilidade | |
| WO2013017910A8 (en) | Extended release pharmaceutical compositions containing paliperidone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |